Biosimilar filgrastim treatment patterns and prevention of febrile neutropenia: A prospective multicentre study in France in patients with solid tumours (the ZOHé study)
Số trang: 13
Loại file: pdf
Dung lượng: 631.96 KB
Lượt xem: 8
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
The ZOHé study was a prospective, non-interventional, multicentre study in France to assess the use of biosimilar filgrastim Zarzio® (Sandoz filgrastim) in routine clinical practice in patients at risk of neutropeniainducing chemotherapy (CT).
Nội dung trích xuất từ tài liệu:
Biosimilar filgrastim treatment patterns and prevention of febrile neutropenia: A prospective multicentre study in France in patients with solid tumours (the ZOHé study)
Nội dung trích xuất từ tài liệu:
Biosimilar filgrastim treatment patterns and prevention of febrile neutropenia: A prospective multicentre study in France in patients with solid tumours (the ZOHé study)
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Biosimilar pharmaceuticals Febrile neutropenia Real-world Solid tumours Guidelines recommendationsGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 167 0 0 -
6 trang 165 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 138 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 107 0 0 -
12 trang 87 0 0
-
19 trang 72 0 0
-
17 trang 60 0 0
-
9 trang 35 0 0
-
11 trang 34 0 0
-
12 trang 33 0 0